PAM
ABBV icon

Pinpoint Asset Management’s AbbVie ABBV Stock Holding History

Pinpoint Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,483
Closed -$3.28M – 89
2024
Q4 		$3.28M Buy
18,483
+6,123
+50% +$1.13M 0.58% 28
2024
Q3 		$2.44M Buy
12,360
+200
+2% +$37.3K 0.52% 29
2024
Q2 		$2.09M Buy
12,160
+900
+8% +$149K 0.29% 38
2024
Q1 		$2.05M Buy
+11,260
New +$1.94M 0.33% 43

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Pinpoint Asset Management's ABBV Position: Q1 2025 in Review

Pinpoint Asset Management sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 18,483 shares — an estimated $3.28M sold.

Pinpoint Asset Management first reported a position in ABBV in Q1 2024 and held it in 4 quarters. The position peaked at $3.28M in Q4 2024. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Pinpoint Asset Management reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Pinpoint Asset Management sold 18,483 AbbVie shares in Q1 2025, an estimated $3.28M.
  • Pinpoint Asset Management first reported a position in AbbVie in Q1 2024 and held it in 4 quarters.
  • Pinpoint Asset Management's AbbVie position peaked at $3.28M in Q4 2024.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Pinpoint Asset Management's 13F filing for Q1 2025, filed 12 May 2025.